Italian medtech industry concerned about proposed DRG revisions
This article was originally published in RAJ Devices
Executive Summary
The Italian medical technology industry association, Assobiomedica, has expressed major concern over new proposals by the government to revise the diagnosis related group reimbursement system in order to cut costs. Karen Finn reports from the 2009 International Medical Device Industry Compliance, Regulatory and Intellectual Property Conference in Rome, Italy, on 25 May.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.